Abstract
An 82-year-old woman treated for advanced lung cancer with gefitinb was admitted to the emergency unit complaining of dyspnea. Chest computed tomography found abnormalities classified as possible diffuse COVID-19 pneumonia. RT-PCR for Sars-Cov-2 was twice negative. PCR for Pneumocystis jirovecii was positive on bronchoalveolar lavage. The final diagnosis was Pneumocystis jirovecii pneumonia. Therefore, physicians must be careful not to misdiagnose COVID-19, especially in cancer patients on small-molecule therapeutics like gefitinib and corticosteroids.
Author supplied keywords
Cite
CITATION STYLE
Barben, J., Quipourt, V., Vovelle, J., Putot, A., & Manckoundia, P. (2021). Not covid-19, don’t overlook pneumocystis in patients on gefitinib! Current Oncology, 28(1), 961–964. https://doi.org/10.3390/curroncol28010094
Register to see more suggestions
Mendeley helps you to discover research relevant for your work.
